EMA Authorised: Lacosamide Accord (lacosamide) — Accord Healthcare S.L.U.

View source ↗

Summary

The European Medicines Agency authorised Lacosamide Accord for epilepsy. The product contains lacosamide and is marketed by Accord Healthcare S.L.U.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Lacosamide Accord (lacosamide)

Snippet

Status: Authorised. Therapeutic area: Epilepsy. MAH: Accord Healthcare S.L.U.. Decision date: 28/05/2025